Search
for
Sort by
Research 211–240 of 1000+
- Synergistic Wound Healing: Unraveling the Multi-Target Effects of Traditional Chinese Medicine and Its Biomaterials on Chronic Wound Pathways
- Nanotechnological reprogramming of the pathological skin microenvironment in scar formation and atopic dermatitis
- Comparative overview of phytoconstituents and pharmacological potential of Trigonella foenum-graecum leaves and seeds
- The senescence-like activity of BMS-470539 is associated with anti-fibrotic actions in models of dermal fibrosis
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- Lichen Planopilaris and Frontal Fibrosing Alopecia as Model Epithelial Stem Cell Diseases
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents
- Fatty acids and related lipid mediators in the regulation of cutaneous inflammation
- Conventional and novel stem cell based therapies for androgenic alopecia
- Epigenetic regulation in adult stem cells and cancers
- New changes in pregnancy and lactation labelling: Review of dermatologic drugs
- Overexpression of Lnk in the Ovaries Is Involved in Insulin Resistance in Women With Polycystic Ovary Syndrome
- Local Corticosteroids for Alopecia Areata: A Narrative Review
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part I Topical and Device-based Treatment
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- A symphony of signals: the intricate role of lncRNAs in dermatological disorders
- Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
- Hair follicle immune privilege in autoimmune and immune-mediated alopecias: paths toward reestablishing immune tolerance
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Novel drugs of United States Food and Drug Administration approved in 2024
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Dermatolojik Problemler ve COVID-19
- Androgenetic Alopecia: Therapy Update
- The Itchy Scalp
- Tinea Capitis: An Overview with Emphasis on Management
- The role of multiomics in revealing the mechanism of skin repair and regeneration
- Scalpel, Toxin, and Performance Pressure: Metabolic, Psychiatric, and Psychosocial Aspects of Aesthetic Medicine in Competitive and Physique Athletes
- Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology
- Nucleic acid-induced chemokine expression in keratinocytes: Implications for skin inflammation